As per the Migraine Research Foundation, “Migraine is an extraordinarily prevalent neurological disease, affecting 39 million men, women, and children in the U.S, which signifies that nearly 1 in 4 U.S. households has someone with migraine”. Similarly, worldwide nearly 1 billion are supposed to be affected by Migraines. Due to undiagnosed and undertreated cases, the overall burden of Migraines is high.
Prominent companies such as Theranica Bio-Electronics, electroCore, Cirrus Healthcare Products, Cefaly, eNeura., Prolivio, Neuros Medical, Salvia Bioelectronics, BMedical Pty Ltd., Neurolief, and others are developing Migraine Treatment Devices. As per DelveInsight’s analysis, currently, among migraine patients, pharmacological treatment is preferred more than medical devices in the 7MM.
In the coming years, the progress in the diagnosis of Migraines, the increased awareness, the launch of potential emerging treatments, advances in understanding the migraine pathophysiology, and better acknowledgment are expected to change the overall dynamics of Migraines. Similarly, the increasing availability of over-the-counter treatment devices and technological advancements in product development will also provide momentum to the Migraine therapeutics market growth.
For more detailed information, visit:
Migraine Therapeutics Market and Treatment Devices